Osteoporosis-pseudoglioma syndrome

Last updated
Osteoporosis-pseudoglioma syndrome
Autosomal recessive - en.svg
Specialty Medical genetics

Osteoporosis-pseudoglioma syndrome or OPGG is a rare genetic condition characterized by early-onset blindness and severe osteoporosis alongside seemingly random bone fractures.

Contents

Signs and symptoms

It is clinically characterized by severe osteoporosis which is usually recognized and posteriorly diagnosed in early childhood. This usually leads to various complications, the primary one being recurrent bone fractures. [1] [2]

Another very common symptom is total blindness, which usually manifests in two ways:

Occasional findings include epilepsy, intellectual disabilities, joint hypermobility, hypotonia, [1] cataracts, microphthalmia, and iris, lens, and vitreous defects. [3]

People with only one copy of the gene mutation involved in this condition (heterozygotes) are at a higher risk of developing exudative vitreoretinopathy and having low bone density, which can consequently result in osteoporosis. [4]

Complications

The condition is associated with various complications, most of which are osseous (related to bone). [1]

They are the following:

Anatomy

Osteoporosis and the complications which are brought to light by it are caused by a decreased level of minerals within the bones. [1]

The visual impairments are caused by a group of ocular conditions known as pseudoglioma. [1]

Genetics

This condition is caused by autosomal recessive missense mutations in the LRP5 gene, located in the long arm of chromosome 11. [5] [6]

This gene normally provides instructions to make a protein that embeds itself in the outer membrane of various cell types. It works alongside a different receptor protein, frizzled-4 (which is made by the FZD4 gene) to send chemical signams from the outside of the cell to the nucleus of said cell. Both proteins (frizzled-4 and LRP5) participate in the Wnt signaling pathway, which are steps that are involved in the development of cells and tissues. It is important for proliferation (cell division), adhesion (cell attachment), migration (cell movement), etc. The protein LRP5 makes is important for the appropriate development and maintenance of multiple tissues. It is involved in guiding the specialization of retinal cells, in establishing proper blood supply to both the retina and the inner ear, and in regulating bone mineral density, the latter of which gives strength to the bones and make them less likely to break. [5]

The mutations in the gene that causes osteoporosis-pseudoglioma either impaire the cells' ability to produce LRP5 protein or they change the single amino acids in the protein. They cannot insert themselves into the outside of the cell, which in turn does not allow them to do their function. Loss-of-function mutations in the LRP5 protein alter the chemical signaling pathways involved in normal bone formation and retinal development, causing the abnormalities that patients with this condition show. [5]

Diagnosis

This condition can be diagnosed through genetic testing, radiographs, and eye exams.[ citation needed ]

Treatment

Treatment is done on the symptoms themselves.[ citation needed ]

Prevalence

Worldwide, this condition has an estimated prevalence of 1 out of every 2,000,000 live births. [3] [7]

History

It was first discovered in 1972 by Bianchine et al. when they described three families with osteogenesis imperfecta, pseudoglioma, retinoblastoma, and recurrence of bone fractures. [8]

Related Research Articles

<span class="mw-page-title-main">Joubert syndrome</span> Medical condition

Joubert syndrome is a rare autosomal recessive genetic disorder that affects the cerebellum, an area of the brain that controls balance and coordination.

<span class="mw-page-title-main">Osteopetrosis</span> Rare disease of the bones

Osteopetrosis, literally 'stone bone', also known as marble bone disease or Albers-Schönberg disease, is an extremely rare inherited disorder whereby the bones harden, becoming denser, in contrast to more prevalent conditions like osteoporosis, in which the bones become less dense and more brittle, or osteomalacia, in which the bones soften. Osteopetrosis can cause bones to dissolve and break.

<span class="mw-page-title-main">Osteogenesis imperfecta</span> Group of genetic disorders resulting in fragile bones

Osteogenesis imperfecta, colloquially known as brittle bone disease, is a group of genetic disorders that all result in bones that break easily. The range of symptoms—on the skeleton as well as on the body's other organs—may be mild to severe. Symptoms found in various types of OI include whites of the eye (sclerae) that are blue instead, short stature, loose joints, hearing loss, breathing problems and problems with the teeth. Potentially life-threatening complications, all of which become more common in more severe OI, include: tearing (dissection) of the major arteries, such as the aorta; pulmonary valve insufficiency secondary to distortion of the ribcage; and basilar invagination.

<span class="mw-page-title-main">Jackson–Weiss syndrome</span> Medical condition

Jackson–Weiss syndrome (JWS) is a genetic disorder characterized by foot abnormalities and the premature fusion of certain bones of the skull (craniosynostosis), which prevents further growth of the skull and affects the shape of the head and face. This genetic disorder can also sometimes cause intellectual disability and crossed eyes. It was characterized in 1976.

<span class="mw-page-title-main">Collagen, type I, alpha 1</span> Mammalian protein found in humans

Collagen, type I, alpha 1, also known as alpha-1 type I collagen, is a protein that in humans is encoded by the COL1A1 gene. COL1A1 encodes the major component of type I collagen, the fibrillar collagen found in most connective tissues, including cartilage.

<span class="mw-page-title-main">Hajdu–Cheney syndrome</span> Medical condition

Hajdu–Cheney syndrome, also called acroosteolysis with osteoporosis and changes in skull and mandible, arthrodentoosteodysplasia and Cheney syndrome, is an extremely rare autosomal dominant congenital disorder of the connective tissue characterized by severe and excessive bone resorption leading to osteoporosis and a wide range of other possible symptoms. Mutations in the NOTCH2 gene, identified in 2011, cause HCS. HCS is so rare that only about 50 cases have been reported worldwide since the discovery of the syndrome in 1948

<span class="mw-page-title-main">Papillorenal syndrome</span> Medical condition

Papillorenal syndrome is an autosomal dominant genetic disorder marked by underdevelopment (hypoplasia) of the kidney and colobomas of the optic nerve.

Metaphyseal dysplasia, or Pyle disease, is a disorder of the bones. It is a rare disease in which the outer part of the shafts of long bones is thinner than normal and there is an increased chance of fractures. Its hallmark feature is an abnormality of the long bones in the arms and legs in which the ends (metaphyses) of the bones are abnormally broad; the shape of the bones resembles a boat oar or paddle. The broad metaphyses are due to enlargement of the spongy inner layer of bone. Although trabecular bone is expanded, the dense outermost layer of bone is thinner than normal. As a result, the bones are fragile and fracture easily. The bone abnormalities in the legs commonly cause knock knees in affected individuals.

<span class="mw-page-title-main">RAPADILINO syndrome</span> Medical condition

RAPADILINO syndrome is an autosomal recessive disorder characterized by:

<span class="mw-page-title-main">VPS13B</span> Protein-coding gene in the species Homo sapiens

Intermembrane lipid transfer protein VPS13B, also known as vacuolar protein sorting-associated 13B, and Cohen syndrome protein 1 is a protein that in humans is encoded by the VPS13B gene. It is a giant protein associated with the Golgi apparatus that is believed to be involved in post-Golgi apparatus sorting and trafficking. Mutations in the human VPS13B gene cause Cohen syndrome.

<span class="mw-page-title-main">LRP5</span> Protein-coding gene in the species Homo sapiens

Low-density lipoprotein receptor-related protein 5 is a protein that in humans is encoded by the LRP5 gene. LRP5 is a key component of the LRP5/LRP6/Frizzled co-receptor group that is involved in canonical Wnt pathway. Mutations in LRP5 can lead to considerable changes in bone mass. A loss-of-function mutation causes osteoporosis pseudoglioma syndrome with a decrease in bone mass, while a gain-of-function mutation causes drastic increases in bone mass.

<span class="mw-page-title-main">Winchester syndrome</span> Rare hereditary connective tissue disease

Winchester syndrome is a rare hereditary connective tissue disease described in 1969, of which the main characteristics are short stature, marked contractures of joints, opacities in the cornea, coarse facial features, dissolution of the carpal and tarsal bones, and osteoporosis. Winchester syndrome was once considered to be related to a similar condition, multicentric osteolysis, nodulosis, and arthropathy (MONA). However, it was discovered that the two are caused by mutations found in different genes; however they mostly produce the same phenotype or clinical picture. Appearances resemble rheumatoid arthritis. Increased uronic acid is demonstrated in cultured fibroblasts from the skin and to a lesser degree in both parents. Despite initial tests not showing increased mucopolysaccharide excretion, the disease was regarded as a mucopolysaccharidosis. Winchester syndrome is thought to be inherited as an autosomal recessive trait.

Hereditary sensory and autonomic neuropathy (HSAN) or hereditary sensory neuropathy (HSN) is a condition used to describe any of the types of this disease which inhibit sensation.

<span class="mw-page-title-main">Parkes Weber syndrome</span> Medical condition

Parkes Weber syndrome (PWS) is a congenital disorder of the vascular system. It is an extremely rare condition, and its exact prevalence is unknown. It is named after British dermatologist Frederick Parkes Weber, who first described the syndrome in 1907.

Warsaw breakage syndrome is a rare genetic condition. Fewer than 10 cases have been reported by 2018. Its clinical manifestations affect several organ systems, and includes microcephaly and severe growth retardation among others.

Holoprosencephaly-ectrodactyly-cleft lip/palate syndrome, also simply known as Hartsfield syndrome, is a rare genetic disorder characterized by the presence of variable holoprosencephaly, ectrodactyly, cleft lip and palate, alongside generalized ectodermal abnormalities. Additional findings include endocrine anomalies and developmental delays.

<span class="mw-page-title-main">Severe intellectual disability-progressive spastic diplegia syndrome</span> Medical condition

Severe intellectual disability-progressive spastic diplegia syndrome is a rare novel genetic disorder characterized by severe intellectual disabilities, ataxia, craniofacial dysmorphisms, and muscle spasticity. It is a type of autosomal dominant syndromic intellectual disability.

<span class="mw-page-title-main">Hypohidrotic ectodermal dysplasia with immune deficiency</span> Medical condition

Hypohidrotic/anhidrotic ectodermal dysplasia with immune deficiency is a rare genetic condition characterized by a combination of the features of ectodermal dysplasia alongside immunodeficiency.

<span class="mw-page-title-main">Calvarial doughnut lesions-bone fragility syndrome</span> Genetic disorder of fragile bones and lesions atop the skull

Calvarial doughnut lesions-bone fragility syndrome, also known as familial calvarial doughnut lesions, is a rare autosomal dominant genetic disorder characterized by mild to moderate fragility of the bones accompanied with calvarial doughnut lesions.

<span class="mw-page-title-main">Spondyloenchondrodysplasia</span> Medical condition

Spondyloenchondrodysplasia is the medical term for a rare spectrum of symptoms that are inherited following an autosomal recessive inheritance pattern. Skeletal anomalies are the usual symptoms of the disorder, although its phenotypical nature is highly variable among patients with the condition, including symptoms such as muscle spasticity or thrombocytopenia purpura. It is a type of immunoosseous dysplasia.

References

  1. 1 2 3 4 5 "Osteoporosis-pseudoglioma syndrome: MedlinePlus Genetics". medlineplus.gov. Retrieved 2022-07-12.
  2. "Osteoporosis-pseudoglioma syndrome — About the Disease — Genetic and Rare Diseases Information Center". rarediseases.info.nih.gov. Retrieved 2022-07-12.
  3. 1 2 "Orphanet: Osteoporosis pseudoglioma syndrome". www.orpha.net. Retrieved 2022-07-12.
  4. "Osteoporosis Pseudoglioma Syndrome OPPG | Boston Children's Hospital". www.childrenshospital.org. Retrieved 2022-07-12.
  5. 1 2 3 "LRP5 gene: MedlinePlus Genetics". medlineplus.gov. Retrieved 2022-07-12.
  6. Ai, Minrong; Heeger, Shauna; Bartels, Cynthia F.; Schelling, Deborah K. (2005-11-01). "Clinical and Molecular Findings in Osteoporosis-Pseudoglioma Syndrome". The American Journal of Human Genetics. 77 (5): 741–753. doi: 10.1086/497706 . ISSN   0002-9297. PMC   1271384 . PMID   16252235.
  7. Braslavsky, Débora; Scaglia, Paula; Sanguineti, Nora; Aza-Carmona, Miriam; Nevado Blanco, Julián; Lapunzina Badia, Pablo D.; Fernández, María Del C.; Ruiz, Olivia; Carmona, Alejandra; Szlago, Marina; Arberas, Claudia (2020-06-01). "[Osteoporosis-pseudoglioma Syndrome: a pediatric case of primary osteoporosis]". Archivos Argentinos de Pediatria. 118 (3): e300–e304. doi: 10.5546/aap.2020.e300 . ISSN   1668-3501. PMID   32470270. S2CID   241377642.
  8. "Entry - #259770 - Osteoporosis-pseudoglioma syndrome; OPPG — OMIM". www.omim.org. Retrieved 2022-07-12.

Further reading